AlzeCure Pharma AB (publ) (STO:ALZCUR)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.955
-0.035 (-1.76%)
Feb 5, 2026, 5:04 PM CET
50.97%
Market Cap228.68M +102.3%
Revenue (ttm)n/a
Net Income-39.15M
EPS-0.42
Shares Out114.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,241
Average Volume59,457
Open1.975
Previous Close1.990
Day's Range1.920 - 1.975
52-Week Range0.812 - 4.950
Beta-0.09
RSI50.58
Earnings DateFeb 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 11
Stock Exchange Nasdaq Stockholm
Ticker Symbol ALZCUR
Full Company Profile

Financial Performance

Financial Statements